Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 225

1.

Disialoganglioside GD2 anti-idiotypic monoclonal antibodies.

Cheung NK, Canete A, Cheung IY, Ye JN, Liu C.

Int J Cancer. 1993 May 28;54(3):499-505.

PMID:
8509225
2.

A novel O-acetylated ganglioside detected by anti-GD2 monoclonal antibodies.

Ye JN, Cheung NK.

Int J Cancer. 1992 Jan 21;50(2):197-201.

PMID:
1730513
3.

Induction of IgG antibodies by an anti-idiotype antibody mimicking disialoganglioside GD2.

Sen G, Chakraborty M, Foon KA, Reisfeld RA, Bhattacharya-Chatterjee MB.

J Immunother. 1998 Jan;21(1):75-83.

PMID:
9456440
4.

Antibody response to murine anti-GD2 monoclonal antibodies: correlation with patient survival.

Cheung NK, Cheung IY, Canete A, Yeh SJ, Kushner B, Bonilla MA, Heller G, Larson SM.

Cancer Res. 1994 Apr 15;54(8):2228-33.

5.

Ganglioside GD2 specificity of monoclonal antibodies to human neuroblastoma cell.

Saito M, Yu RK, Cheung NK.

Biochem Biophys Res Commun. 1985 Feb 28;127(1):1-7.

PMID:
2579648
6.

Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes.

Riemer AB, Förster-Waldl E, Brämswig KH, Pollak A, Zielinski CC, Pehamberger H, Lode HN, Scheiner O, Jensen-Jarolim E.

Eur J Immunol. 2006 May;36(5):1267-74.

7.

Preclinical evaluation in nonhuman primates of murine monoclonal anti-idiotype antibody that mimics the disialoganglioside GD2.

Sen G, Chakraborty M, Foon KA, Reisfeld RA, Bhattacharya-Chatterjee M.

Clin Cancer Res. 1997 Nov;3(11):1969-76.

8.

The idiotype (Id) cascade in mice elicited the production of anti-R24 Id and anti-anti-Id monoclonal antibodies with antitumor and protective activity against human melanoma.

Ramos AS, Parise CB, Travassos LR, Han SW, de Campos-Lima PO, de Moraes JZ.

Cancer Sci. 2011 Jan;102(1):64-70. doi: 10.1111/j.1349-7006.2010.01771.x. Epub 2010 Nov 10.

9.

Generation of a human anti-idiotypic antibody that mimics the GD2 antigen.

Saleh MN, Stapleton JD, Khazaeli MB, LoBuglio AF.

J Immunol. 1993 Sep 15;151(6):3390-8.

PMID:
8376782
10.

Antibodies against GD2 ganglioside can eradicate syngeneic cancer micrometastases.

Zhang H, Zhang S, Cheung NK, Ragupathi G, Livingston PO.

Cancer Res. 1998 Jul 1;58(13):2844-9.

11.

Syngeneic anti-idiotypic monoclonal antibodies to an anti-NeuGc-containing ganglioside monoclonal antibody.

Vázquez AM, Pérez A, Hernández AM, Macías A, Alfonso M, Bombino G, Pérez R.

Hybridoma. 1998 Dec;17(6):527-34.

PMID:
9890708
12.

Tumor targeting of the IL-15 superagonist RLI by an anti-GD2 antibody strongly enhances its antitumor potency.

Vincent M, Bessard A, Cochonneau D, Teppaz G, Solé V, Maillasson M, Birklé S, Garrigue-Antar L, Quéméner A, Jacques Y.

Int J Cancer. 2013 Aug 1;133(3):757-65. doi: 10.1002/ijc.28059. Epub 2013 Feb 25.

13.

Targeting of ganglioside GD2 monoclonal antibody to neuroblastoma.

Cheung NK, Neely JE, Landmeier B, Nelson D, Miraldi F.

J Nucl Med. 1987 Oct;28(10):1577-83.

14.

Successful multifold dose escalation of anti-GD2 monoclonal antibody 3F8 in patients with neuroblastoma: a phase I study.

Kushner BH, Kramer K, Modak S, Cheung NK.

J Clin Oncol. 2011 Mar 20;29(9):1168-74. doi: 10.1200/JCO.2010.28.3317. Epub 2011 Feb 22.

15.

Localization of GD2-specific monoclonal antibody 3F8 in human osteosarcoma.

Heiner JP, Miraldi F, Kallick S, Makley J, Neely J, Smith-Mensah WH, Cheung NK.

Cancer Res. 1987 Oct 15;47(20):5377-81.

16.

DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses.

Bolesta E, Kowalczyk A, Wierzbicki A, Rotkiewicz P, Bambach B, Tsao CY, Horwacik I, Kolinski A, Rokita H, Brecher M, Wang X, Ferrone S, Kozbor D.

Cancer Res. 2005 Apr 15;65(8):3410-8.

17.

Anti-idiotype monoclonal antibody carrying the internal image of ganglioside GM3.

Yamamoto S, Yamamoto T, Saxton RE, Hoon DS, Irie RF.

J Natl Cancer Inst. 1990 Nov 21;82(22):1757-60.

PMID:
1700134
18.

Induction of cellular immunity by anti-idiotypic antibodies mimicking GD2 ganglioside.

Basak S, Birebent B, Purev E, Somasundaram R, Maruyama H, Zaloudik J, Swoboda R, Strittmatter W, Li W, Luckenbach A, Song H, Li J, Sproesser K, Guerry D, Nair S, Furukawa K, Herlyn D.

Cancer Immunol Immunother. 2003 Mar;52(3):145-54. Epub 2003 Feb 11.

PMID:
12649743
20.

Murine monoclonal anti-idiotypic antibody as a surrogate antigen for human Her-2/neu.

Baral R, Sherrat A, Das R, Foon KA, Bhattacharya-Chatterjee M.

Int J Cancer. 2001 Apr 1;92(1):88-95.

Supplemental Content

Support Center